PubMed · 1993 · 57 citations · 7 references
MedicinePharmacologyPharmacotherapyCardiac TransplantationClinical PharmacologyTransplant PharmacotherapyBlood Pressure ManagementCardiovascular DiseaseCardiovascular PharmacologyHypertension ManagementHypertension PharmacotherapyTransplant PharmacologyHypertension After TransplantationInduced HypertensionLipid Profile ChangesOmega-3 Fatty AcidsOmega-6 Fatty AcidsOral SupplementationPost-transplant HypertensionVascular Resistance
BACKGROUND: Cyclosporine-induced hypertension may be related to vasoconstriction of the afferent arterioles in the glomeruli caused by changes in the prostaglandin profile. omega-3 Fatty acids have demonstrated vasodilatory properties related to a favorable effect in the prostaglandin profile. The purpose of this study was to evaluate the antihypertensive effects of oral supplementation with omega-3 fatty acids in cyclosporine-treated cardiac transplant recipients. METHODS AND RESULTS: The study consisted of 20 orthotopic cardiac transplant recipients with hypertension who were prospectively randomized in a double-blind fashion to receive either omega-6 fatty acids (placebo group, n = 10) or omega-3 fatty acids (treatment group, n = 10). Blood pressure, systemic hemodynamics, two-dimensional guided M-mode and Doppler echocardiography, and laboratory values (serum creatinine, lipid profile) were recorded at baseline and at 12 weeks. The treatment group demonstrated a significant reduction in mean arterial pressure (120 +/- 7 versus 102 +/- 7 mm Hg; P = .0001) associated with a decrease in systemic vascular resistance (2107 +/- 45 versus 1426 +/- 60 dynes.sec.cm-5; P = .0001). No changes in indexes of left ventricular structure and function occurred, except for a modest decrease in deceleration time (211 +/- 10 versus 182 +/- 12 milliseconds; P = .05), an index of left ventricular diastolic function. CONCLUSIONS: omega-3 Fatty acids (3 g/d) reduce blood pressure by decreasing systemic vascular resistance and, therefore, can be used as an adjuvant for the treatment of hypertension in cyclosporine-treated cardiac transplant recipients. Their vasodilatory effect may be related to a beneficial change in the prostaglandin profile.
7
Mental Health Survey of the Iranian Adult Population in 2015.
Ahmad Ali Noorbala, Soghrat Faghihzadeh, Seyed Abbas Bagheri Yazdi et al. · PubMed · 2017 · 125 citations
Prevalence of Hypertension in Iran 1980-2012: A Systematic Review.
Masoud Mirzaei, Setareh Moayedallaie, Latife Jabbari et al. · PubMed · 2016 · 65 citations · Full text
Sadaf G Sepanlou, Mahboubeh Parsaeian, Kristopher J Krohn et al. · PubMed · 2017 · 44 citations · Full text
Public Health, Health Policy, Population Health Sciences +17